Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Electroporation for Urinary Bladder Tumors
NCT07555769Phase 1Recruiting
- Start
- Oct 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of calcium gluconate in urothelial carcinoma (UC). Primary endpoint: Adverse Events at 3 months. Started Oct 2026; status: recruiting.
02
Drugs
calcium gluconate
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT07555769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07555769.